Search

Copyright of Revista de Psicoterapia is the property of Revista de Psiquiatria y Psicologia Humanista, S.L. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Fisioterapia Brasil is the property of Atlantica Editora and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introdução: A endometriose é uma doença que tem enorme impacto negativo na qualidade de vida das mulheres, principalmente pelo seu caráter crónico e difícil diagnóstico. A dispareunia (dor na relação sexual penetrativa) é um dos sintomas mais comuns e um poderoso inibidor do ciclo de resposta sexual. Existe um consenso internacional de que o treino dos músculos do pavimento pélvico deve ser a primeira linha de tratamento da incontinência urinária de esforço e do prolapso de órgão pélvico, no entanto, pouco se sabe sobre os efeitos na disfunção sexual feminina; Objetivo: perceber o efeito da fisioterapia na dispareunia, na função sexual e na qualidade de vida e de uma jovem com endometriose. Material e Métodos: Foram realizadas 8 sessões de intervenção, uma vez por semana, durante aproximadamente 60 minutos, que incluíram ensino da anatomofisiologia do pavimento pélvico, modificação comportamental, técnicas específicas de terapia manual, treino dos músculos do pavimento pélvico e Pilates clínico. Procedeu-se à mensuração da dor com a Escala Visual Analógica (EVA), da função sexual com o Índice de Funcionamento Sexual Feminino (FSFI) e da qualidade de vida com o Questionário de Perfil de Saúde da Endometriose (EHP); Resultados: A fisioterapia demonstrou um efeito favorável nas três variáveis medidas: verificou-se redução da dor de 8/10 para 3/10 (EVA), verificou-se uma melhoria de 11,6 na pontuação total, 1,8 na dimensão excitação, 1,8 na lubrificação, 4 no orgasmo, 0,8 na satisfação e 3,2 na dor (FSFI) e observou-se uma melhoria nas dimensões suporte social, vida no trabalho, relações com os filhos e relações sexuais (EHP). Conclusões: o objetivo do estudo de caso foi atingido. Apesar de não se terem verificado melhorias em todas as dimensões da qualidade de vida da utente, a intervenção foi suficientemente importante para permitir o reinício da sua vida sexual, com uma redução significativa da dispareunia, o que foi de encontro à sua expetativa.

Copyright of Fisioterapia Brasil is the property of Atlantica Editora and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: endometriosis affects 5-10% of women of reproductive age worldwide. The aim was to evaluate chronic pelvic pain (CPP), its functional repercussion and depression in women with endometriosis contacted through the Endometriosis Sufferers Associations of Euskadi, Catalonia, Valencia, Madrid and Extremadura between October 2019 and February 2021. Material and method: the study was analytical and cross-sectional. The CPP questionnaire in women (CPPQ-Mohedo) and the Beck depression inventory (BDI-II) were applied in women with and without a diagnosis of endometriosis. The study included 214 women aged 18-52 years, 136 with a diagnosis of endometriosis, 74 with surgical treatment (ETQ), 62 without surgery (ESTQ) and 78 as a control group (CG). Results: the age was 31.6 ± 7.7 and 36.7 ± 5.8 years in the control and endometriosis groups respectively. 61.3 % ESTQ and 63.5 % ETQ had perineal pain, 82.3 % ESTQ and 86.5 % ETQ manifested subumbilical pain. Vulvar and clitoral pain was less than 30 % and 20 % in ESTQ and ETQ women, respectively. Dyspareunia was reported in 78.8 % and 66.7 % of ESTQ and ETQ women, respectively. In women with endometriosis, pain on the VAS scale was moderate (4.0), the total CPP score was intermediate (13.5). The 84.6 % presented moderate-severe depression and perceived their health as «dreadful» (> 30 %) with impairment in their activities. Conclusion: CPP has an impact on physical and psychological well-being in women with endometriosis in Spain. [ABSTRACT FROM AUTHOR]

Copyright of Fisioterapia Brasil is the property of Atlantica Editora and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The genitourinary syndrome of menopause (SGUM) describes the symptoms and signs of the vulvo-vaginal and lower urinary tract, of a chronic and progressive nature, secondary to a clinical state of hypoestrogenism that characterizes postmenopause. The present review aims to describe and analyze the different nonhormone therapeutic alternatives, with their advantages and disadvantages, in order to offer readers a full range of options when establishing treatment in a woman with SGUM. A database search, including original research, expert consensus, systematic reviews and meta-analysis. The current evidence for various pharmacological and nonpharmacological (non-hormonal) therapeutic modalities has been reviewed, finding that moisturizers and lubricants are the first line of therapy to provide short-term relief of vaginal dryness (mild to moderate) and dyspareunia; however, treatment must be individualized. It is concluded that there are numerous treatments available, each with benefits and limitations. Substantial gaps in the scientific evidence for safe and effective therapies are highlighted, as well as the need for future research. [ABSTRACT FROM AUTHOR]

La dispareunia masculina es un síntoma poco conocido, pero con gran impacto en la calidad de vida de los hombres que lo padecen. Existe escasa investigación sobre este tema en comparación con su contraparte femenina. En su etiología se presenta una amplia variedad de patologías con predominancia de componentes orgánicos, por lo que es importante conocer y entender las causas para el oportuno tratamiento. Para el diagnóstico de la dispareunia, una adecuada historia, anamnesis, y examen físico, son fundamentales para orientar a su posterior evolución y manejo del trastorno mediante las nuevas opciones de tratamiento que se cuenta en la actualidad, donde es de utilidad el abordaje individualizado y teniendo en cuenta otros factores emocionales y socio-culturales. En esta revisión, se expone un enfoque sobre la frecuencia, diagnóstico, evaluación y tratamiento de este síntoma bastante complejo, que en algunas oportunidades puede tener repercusión en las relaciones interpersonales.

Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A cross-sectional study was conducted to determine the prevalence of dyspareunia in women with vaginal delivery, to assess possible risk factors and the association with episiotomy. Women attended for vaginal delivery, between 2012 and 2017, were admitted in two high complexity clinics in Armenia (Colombia). The Female Sexual Function Index (IFFS-6) questionnaire was used to assess sexual function. The results report a prevalence of dyspareunia of 59.37%, prevalent in women undergoing episiotomy (OR: 68,17; IC95%: 60,57-79,15). Regarding the association of episiotomy with the presence of dyspareunia, a significant association was found with mid-lateral episiotomy (OR: 8,17; IC95%: 2,15-56,32), sphincter injury (OR: 7,32; IC95%: 4,86-12,75), and suture dehiscence (OR: 6,48; IC95%: 4,92-14,28). The following were observed as risk factors: history of endometriosis (OR: 11,6; IC95%: 9,15-17,52), chronic pelvic pain (OR: 3,56; IC95%: 2,21-6,32) and STIs (OR: 2,67; IC95%: 1,54-5,14), p = 0,003). It is concluded that the prevalence of dyspareunia in women with vaginal delivery, attended in Armenia, varies depending on the episiotomy performance. Both are associated with the complications of this and other backgrounds. [ABSTRACT FROM AUTHOR]

Introduction: Within sexual disorders due to pain, dyspareunia and vaginismus are studied. The Diagnostic and Statistical Manual of Mental Disorders V encompasses them under the category of pelvic pain and penetration disorder. In Cuba, there are not many theoretical references of these diseases. Objective: Systematize and update the theoretical references related to dyspareunia and vaginismus, from a sexological approach Methods: A review of the literature published on the subject, of the last ten years, in full text, in the SciELO databases and from the search with academic Google with the keywords: sexual disorders due to pain, dyspareunia and vaginismus. Development: Dyspareunia and vaginismus have a multifactorial etiology and varying degrees of impairment of sexual enjoyment of couples. The essential aspects of both entities are presented, fundamentally the classification, etiology, clinical characterization, evaluation and treatment. Conclusions: Dyspareunia and vaginismus are two conditions that affect full and satisfactory sex life and require specialized knowledge, guidance and treatment for the results to be satisfactory.

Benign cystic mesothelioma is a rare tumor originated from mesenchymal cells of the abdominal and pelvic peritoneum. This rare tumor should be considered in the differential diagnosis of young women presenting with abdominal pain and a multicystic abdominal mass. Keywords: Benign cystic mesothelioma; pelvic pain; dispareunia

In the postpartum period, female sexual function may be altered as a result of physical, psychological and social changes. It is common for mothers to report discomfort and / or pain during sexual intercourse at different postpartum periods, from the first sexual intercourse to one year after delivery and beyond, which characterizes sexual dysfunction. Thus, this study proposes to analyze the scientific production about the factors associated with dyspareunia in the postpartum period. An integrative review was performed on the LILACS, PUBMED and MEDLINE databases using the descriptors: Sexual dysfunction, dyspareunia and postpartum. Initially 18 articles were found, 10 of which were selected to compose the sample and to fit the study eligibility criteria. The results showed that dyspareunia appears in most studies as one of the main postpartum sexual dysfunctions, compromising desire, sexual satisfaction and frequency of sexual intercourse. Supposedly related to normal delivery, by the presence of episiotomy and / or lacerations. It was concluded that the chosen theme is relevant to the academic community, health professionals and researchers, so that they can prevent postpartum dyspareunia and, in case of its existence, know how to intervene and provide quality care to reduce the discomforts generated. for this pathology during the puerperium. [ABSTRACT FROM AUTHOR]

Copyright of Fisioterapia Brasil is the property of Atlantica Editora and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Efek samping radioterapi adalah pemendekan dan pengeringan vagina yang menyebabkan nyeri saat melakukan hubungan seksual (dispareunia). Hal ini mengakibatkan gangguan fungsi seksual yaitu keinginan, gairah, orgasme, dan kepuasan. Penelitian ini bertujuan untuk melihat efektivitas latihan kegel dalam mengatasi keluhan nyeri saat berhubungan seksual pada perempuan pasca terapi kanker serviks. Penelitian ini menggunakan desain penelitian kuasi eksperimen dengan jumlah responsden 26 orang kelompok intervensi dan 26 orang kelompok kontrol pada perempuan setelah radioterapi. Tingkat nyeri dalam penelitian ini diukur dengan Female Sexual Function Index (FSFI). Pengaruh latihan kegel terhadap nyeri diuji dengan t-tes. Hasil penelitian menunjukkan adanya perbedaan yang bermakna pada kedua kelompok dengan nilai p=0.002. Latihan kegel terbukti menurunkan nyeri saat berhubungan seksual (dispareunia) sebanyak 3,897 kali (OR=3,897). Berdasarkan hasil penelitian ini, perawat diharapkan dapat memberikan intervensi latihan kegel untuk menurunkan nyeri pasca terapi kanker serviks.

Copyright of Fisioterapia Brasil is the property of Atlantica Editora and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Santiago Palacios,1 María Jesús Cancelo2 1Palacios Institute of Women’s Health, Madrid, Spain; 2Gynecology and Obstetrics Department, Guadalajara University Hospital, University of Alcalá, Spain Abstract: The physiological decrease in vaginal estrogens is accountable for the emergence of vulvar and vaginal atrophy (VVA) and its related symptoms such as vaginal dryness, dyspareunia, vaginal and/or vulvar irritation or itching, and dysuria. The repercussion of these symptoms on quality of life often makes it necessary to initiate treatment. Up until now, the treatments available included vaginal moisturizers and lubricants, local estrogens, and hormonal therapy. However, therapeutic options have now been increased with the approval of 60 mg ospemifene, the first nonhormonal oral treatment with an agonist effect on the vaginal epithelium and an endometrial and breast safety profile which makes it unique. This is the first selective estrogen receptor modulator indicated in women with moderate-to-severe vaginal atrophy not eligible for local estrogen treatment. Considering that “local estrogen noneligible women” are those in whom such treatment cannot be administered either because it is contraindicated or due to skill issues, who are averse to the mode and convenience of vaginal products’ administration or to their use on account of potential systemic absorption, or those who demonstrate dissatisfaction in terms of efficacy and safety, it is clear that there is a significant unmet medical need in VVA management. In fact, a great number of women show lack of adherence, dropping out of at least one VVA treatment, including nonhormonal moisturizers and lubricants, which they consider to be ineffective and uncomfortable. If they could choose, many of them may opt for oral treatment. In Phase III studies, ospemifene demonstrated efficacy in vaginal dryness and dyspareunia, regenerating vaginal cells, improving lubrication, and reducing pain during sexual intercourse. Symptoms improved in the first 4 weeks and endured for up to 1 year. Additionally, it demonstrated a good endometrial, cardiovascular system, and breast safety profile. Keywords: ospemifene, vulvar and vaginal atrophy, dyspareunia, therapeutic options

Resumo Objetivos: verificar a prevalência de dispareunia no terceiro trimestre gestacional e fatores associados. Métodos: foram avaliadas 202 puérperas. Para a coleta de dados foram utilizados um questionário sociodemográfico; questionário ICIQ-Short Form; questionário de constipação intestinal e, para a avaliação da dispareunia foram utilizadas as questões do questionário FSFI. Os dados foram analisados com os testes qui quadrado, U de Mann Whitney e teste de Wilcoxon, p

Objective: To determine the prevalence of the genitourinary syndrome of menopause in a population of sexually active women 40 years of age or older. Materials and methods: Descriptive crosssectional study which included women diagnosed with menopause, sexually active over the past six weeks and residents of the Department of Quindío in the coffee growing Andean region of Colombia. Excluded were women with surgical menopause, illiterate, and with mental disorders or deficit. The study was conducted in a private referral centre between 2013 and 2016. Consecutive convenience sampling was used. Measured variables included demographics, vulvovaginal and lower urinary tract symptoms associated with the genitourinary syndrome of menopause, and the presence of global sexual dysfunction, using the Female Sexual Function Index validated in Spanish and by type of dysfunction. A descriptive analysis of the data was performed applying absolute and relative frequency measurements. Prevalence was calculated as the number of women with genitourinary syndrome of menopause/number of women interviewed. Results: Of a total of 597 women selected to participate in the study, 558 (93.46%) were included in the final analysis. The prevalence of the genitourinary syndrome of menopause was 51.61% (62.88% in women over 55 years of age and 39.32% in women under 55). The prevalence of sexual dysfunction in the study group was 67.2%. Findings included altered desire (67.2%), arousal (45.16%), orgasm (44.08%), and lubrication (32.25%), as well as pain during intercourse (13.97%). Conclusion: A high prevalence of the genitourinary syndrome of menopause and sexual dysfunction was found in the study population. Population studies are required in order to determine the size of the problem in the Latin American region. [ABSTRACT FROM AUTHOR]

Objective: To assess the prevalence of the urinary tract infection (UTI), urinary incontinence (UI), anal incontinence (AI) and dyspareunia among primiparous women, as well as to identify the association between dyspareunia and UI and mode of birth. Material and methods: Prospective observational study carried out with 96 post-partum women (72 normal births and 24 caesarean section), two and six months after birth. Data were collected via prenatal cards, medical registers and interviews with women between January and August, 2014, at the Centro do Parto Normal do Pronto Socorro e Maternidade Municipal Zoraide Eva das Dores, located in Itapecerica da Serra, São Paulo, and at Health Centers in the Itapecerica da Serra and the cities of Juquitiba, São Lourenço and Embú-Guaçú. Results: During pregnancy, 52.1% of women reported UTI and 30.2%, UI. Two and six months after birth, there was a prevalence of 4.2% and 11.8% of UTI, 17.7% and 11.8% of UI, 8.4% of AI (6.3% of flatus incontinence and 2.1% of feces) and 2.0% (only flatus incontinence; there was no faecal incontinence); and 48.1% and 17.8% of dyspareunia, respectively. There was no statistical association between the mode of delivery and dyspareunia and UI (p=0.742 and p=0.738; respectively). Conclusions: The most frequent pelvic floor dysfunctions (PFD) after birth were IU and dyspareunia. There was spontaneous reduction of the PFD in the sixth month after birth. The early identification of these diseases is extremely important to prevent, diagnose and treat any harm to women's physical and emotional health. [ABSTRACT FROM AUTHOR]

Objective: To determine the prevalence and to characterise sexual dysfunction in a population of sexually active women with ages ranging between 18 and 72 years, in 12 Colombian cities. Material and methods: Descriptive cross-sectional study that included women 18 years of age and older, sexually active within the past six weeks, living in Colombia. Excluded were illiterate and pregnant women, women in the first 6 months postpartum, women with a psychiatric disease or neurological deficit, and women with a history of cancer. The study was conducted in outpatient gynaecological services of private hospitals in twelve cities (Bogotá, Medellín, Cali, Barranquilla, Cartagena, Cúcuta, Ibagué, Bucaramanga, Villavicencio, Pereira, Manizales and Armenia) between June 2009 and December 2016. A consecutive sampling method was used. The "Female Sexual Function Index" validated in Spanish was applied. Sociodemographic variables, a history of sexual and reproductive health, sexual behaviour, and frequency of overall sexual dysfunction and by type of dysfunction assessed were measured. A descriptive analysis of the data was performed using absolute and relative measurements. A stratified description was made by age under or over 40 years. Results: Of a total of 72,894 candidates for enrolment, 50,991 (69,95%) were ultimate analysed. Mean age was 30.9±10.8 years. The prevalence of sexual dysfunction in the study group was 32.97% (16,812 women). The score on the FSFI in the affected women was 24.07±6.18 points. Issues were found with libido in 32.97%, orgasm in 21.93%, arousal in 16,86%, lubrication in 14,79%, and pain in 7.56%. Median sexual dysfunction per woman was 2, found in 64.16%. Conclusion: Among Colombian women, a prevalence of sexual dysfunction is found in close to one-third of the population, characterised mainly by issues with libido and orgasm. Interventions are required in order to establish an immediate diagnostic and therapeutic plan. [ABSTRACT FROM AUTHOR]

Copyright of Revista Colombiana de Obstetricia y Ginecologia is the property of Federacion Colombiana de Asociaciones de Obstetricia y Ginecologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To evaluate the clinical response of patients with symptoms of genitourinary syndrome of menopause after application of microablative fractional radiofrequency in the vagina and vaginal introitus. Methods: Fourteen patients with symptoms of genitourinary syndrome of menopause underwent three applications of microablative fractional radiofrequency with a 30-day interval, using the Wavetronic 6000HF-FRAXX device and a fractional vaginal electrode. The questionnaires World Health Organization Quality of Life (for quality of life evaluation), Female Sexual Function Index and Quality of Life Adapted Questionnaire in the Domain of Sexual Satisfaction (for sexual function and satisfaction evaluation) were administered before and after the applications (30 to 60 days after the last procedure), in addition to the satisfaction questionnaire after procedure. Results: There was an increase in almost all dimensions on average in quality of life, with statistical significance only in the health domain. There was a significant improvement in the sexual domains in almost all dimensions. All patients stopped using lubricant during intercourse after treatment. In the satisfaction questionnaire after treatment, we observed that the vast majority felt cured or much better (29% and 64%, respectively, total of 92.6%) and were very satisfied or satisfied (43 and 57%, respectively, total of 100%). The only patient who reported little improvement had an 18-year postmenopausal history and was treatment naïve. Conclusion: Microablative fractional radiofrequency was effective in treating symptoms of vaginal dryness and dyspareunia, and eliminated the use of vaginal lubricant during the period observed. Since this is a pilot study with a small number of patients, further studies are required to corroborate our findings and evaluate the long-term effects of microablative fractional radiofrequency on the vaginal tissue. [ABSTRACT FROM AUTHOR]

Os objetivos foram verificar a dispareunia, a dor perineal e as alterações na cicatrização perineal em mulheres submetidas à episiotomia. Estudo longitudinal que deu continuidade ao ensaio clínico que avaliou a eficácia do laser em baixa intensidade na redução da dor perineal nessas mulheres. Foi conduzido no Amparo Maternal, cidade de São Paulo. Participaram 85 e 79 mulheres que foram entrevistadas aos dois meses (janeiro a maio de 2010) e seis meses após o parto (junho a setembro de 2010), respectivamente. Verificou-se dor perineal em 16,5% e 5,1% das mulheres e de dispareunia em 69,7% e 29,2% delas, dois e seis meses após o parto, respectivamente. Aos seis meses, quase metade das participantes referiu dor perineal e alguma alteração na cicatrização: alterações na sensibilidade e na coloração da pele na região perineal e deiscência. Concluiu-se que dor perineal e a dispareunia são morbidades frequentes no pós-parto. ABSTRACT The objectives were to identify dyspareunia, perineal pain and abnormalities in the perineal woundhealing in women undergoing episiotomy. Longitudinal study that continued the clinical trial that evaluated the effectivenesso flow intensity laser in reducing perineal pain in these women. It was carried out in the Amparo Maternal, cityof São Paulo,with85 and 79 women, who were interviewe dattwo months (from January to May, 2010) and six months postpartum (from June to September, 2010), respectively. Perineal painwasverifiedin 16.5% and 5.1% of women and dyspareunia in 69.7% and 29.2% of them, att woand six months post partum, respectively. At six months, almost halfof the participants reported perineal pain and some abnormality in the wound healing: changes in sensitivity and color of the skin in the perineal region and dehiscence. We concluded that perineal painand dyspareunia are common post partum morbidities. RESUMEN Los objetivos fueron verificar la dispareunia, el dolor perineal y las modificaciones en la cicatrización de la herida perineal en mujeres sometidas a la episiotomía. Estudio longitudinal derivado de ensayo clínico que evaluó la eficacia del laser de baja intensidad en la reducción del dolor perineal en estas mujeres. Fue realizado en el hospital Amparo Maternal, São Paulo-Brasil. Participaron 85 y 79 mujeres entrevistadas con dos (enero a mayo de 2010) y seis meses de post-parto (junio a septiembre de 2010), respectivamente. Se verificó dolor perineal en 16,5% y 5,1% de las mujeres y dispareunia en 69,7% y 29,2% de ellas, dos y seis meses después del parto, respectivamente. A los seis meses, casi mitad de las participantes reportaron dolor perineal y modificaciones en la cicatrización de la herida, como sensibilidad, color de la piel y dehiscencia. Se concluye que dolor perineal y dispareunia son morbilidades comunes en el postparto.

OBJETIVO: Determinar la prevalencia de dispareunia y los factores de riesgo asociados en población femenina en edades de 25 a 54 años. MATERIAL Y MÉTODOS: Se analizó información de 1183 mujeres sexualmente activas que participaron en un estudio poblacional de tipo transversal en la ciudad de Hermosillo, Sonora. La asociación entre dispareunia y variables sociodemográficas, antecedentes médicos y violencia sexual se analizó usando regresión logística múltiple. RESULTADOS: La prevalencia de dispareunia durante el año previo a la encuesta fue de 12.3% (IC 95% 10.5-14.4%). Después de controlar por la ocupación, se encontró que la dispareunia estuvo asociada con mujeres jóvenes (25-34 años), antecedentes de enfermedades de transmisión sexual y/o enfermedad inflamatoria de la pelvis, infección urinaria crónica, colitis y violencia sexual. CONCLUSIÓN: Es urgente incrementar el escrutinio y la atención de la dispareunia en el contexto de los programas nacionales de salud sexual y reproductiva y en los servicios de atención primaria a la salud.OBJECTIVE: To determine the prevalence of dyspareunia among women aged 25-54 and its associated risk factors. MATERIAL AND METHODS: A cross-sectional population-based study was carried out in the city of Hermosillo, Sonora and data from 1183 sexually active women were analyzed. A multiple logistic regression was computed to analyze the association between dyspareunia and sociodemographic characteristics, medical conditions and sexual violence. RESULTS: The 12-month prevalence of dyspareunia was estimated to be 12.3% (95% CI 10.5, 14.4). After adjustment for working conditions, dyspareunia was associated with younger ages (25-34 years), history of sexually transmitted diseases/pelvic inflammatory disease, chronic urinary tract infections, colitis and history of sexual violence. CONCLUSION: Increased attention to this condition by reproductive health programs and primary care services is urgently needed in Mexico.

OBJETIVOS: determinar a prevalência de disfunções sexuais femininas em mulheres atendidas no Centro de Atenção à Mulher do Instituto Materno Infantil Prof. Fernando Figueira, IMIP, utilizando os critérios de classificação da 4ª. edição do Manual Diagnóstico e Estatístico de Transtornos Mentais. MÉTODOS: estudo transversal, cujos dados foram obtidos em formulário estruturado, aplicado durante entrevista individual com 100 mulheres com idades entre 20 e 39 anos, no período de abril a maio de 2004. Determinou-se a freqüência das disfunções sexuais femininas e sua associação com as características biológicas, demográficas e reprodutivas das mulheres, assim como sua associação com o método contraceptivo usado no momento da entrevista. RESULTADOS: a prevalência de algum tipo de disfunção sexual foi de 36%. A disfunção do orgasmo foi constatada em 18% das entrevistadas e dispareunia em 13% das mulheres no último mês anterior ao estudo. A disfunção do desejo foi relatada por 11% das mulheres, 8% tiveram disfunção da excitação e apenas 1% referiram vaginismo. Observou-se uma associação positiva estatisticamente significativa das disfunções sexuais femininas com a idade da coitarca menor que 20 anos, freqüência de apenas uma relação sexual por semana ou menos e lactação. CONCLUSÕES: os achados sugerem que diversas medidas preventivas podem impedir a ocorrência de disfunções sexuais femininas em determinado grupo de pacientes: melhorar o nível educacional da população, facilitar seu acesso à informação e aconselhamento, estimular ações preventivas de saúde e por fim investir em programas de treinamento e educação médica continuada.OBJECTIVES: to determine sexual dysfunctions of the women seen at the Centro de Atenção à Mulher of the Instituto Materno Infantil Prof. Fernando Figueira, IMIP, based on the classification criteria of the 4th edition of Diagnostic and Statistical Manual of Mental Disturbances. METHODS: a cross sectional study with data obtained through a structured form applied during individual interviews with 100 women aged between 20 and 39 years old in the period of April to May, 2004. The frequency of female sexual dysfunctions and association with biological, demographic and reproductive characteristics of the women, including contraceptives used, was determined. RESULTS: prevalence of at least some type of sexual dysfunction was of 36%. Orgasm dysfunction occurred in 18% of the respondents and dyspareunia appeared in 13% of the women during the month prior to the study. Sexual appetite dysfunction was reported by 11% of the women, 8% had excitation dysfunction and only 1% reported vaginismus. A positive, statistically significant association of female sexual dysfunction and the first sexual intercourse, before 20 years old, frequency of only one sexual intercourse per week or less, and breastfeeding. CONCLUSIONS: the findings suggest that different preventive measures could stop the occurrence of female sexual dysfunctions in a specific group of patients: improving education, facilitating the access to information and counseling, encouraging health preventive policies and finally investments in ongoing medical training and education.

Objectives: to establish the prevalence of dyspareunia in the third gestational trimester and associated factors. Methods: 202 puerperal women were evaluated. Data was collected using a socio-demographic questionnaire; the ICIQ-Short Form questionnaire; an intestinal constipation questionnaire;and, questions from the FSFI questionnaire to evaluate dyspareunia. The data were analyzed using the chi-squared, Mann- Whitney U and Wilcoxon tests, p<0.05. Results: the prevalence of dyspareunia in the third gestational trimester was 48.5% (n=98), compared with 15.3% (n=31) before gestation. The factors associated with dyspareunia in this period were: constipation in the third trimester of gestation (p=0.05); urinary incontinence in the third trimester of gestation (p<0.001) and dyspareunia prior to gestation (p=0.01). The mean age of women with dyspareunia was significantly higher than that of those without dyspareunia (p=0.01). Conclusions: the prevalence of dyspareunia is high during gestation and is associated with alterations in the functions of the pelvic saddle, such as the presence of urinary incontinenceand constipation, and prior dyspareunia. [ABSTRACT FROM AUTHOR]

CONTEXTUALIZAÇÃO As disfunções sexuais são caracterizadas pela ocorrência de desconforto e/ou dor durante alguma fase do ato sexual (desejo, excitação, orgasmo e resolução). Além disso, possuem caráter multifatorial de ocorrência, alcançando elevados índices de prevalência em mulheres. De acordo com a literatura, as disfunções do assoalho pélvico ocorrem de forma associadas, sendo frequentemente encontrados casos de incontinência urinária juntamente a desordens sexuais ou defecatórias. Estudos têm demonstrado a ocorrência de dispareunia entre mulheres desportistas durante a penetração vaginal, limitando, assim, a atividade sexual. Portanto, as disfunções sexuais englobam vários aspectos que afetam a saúde da mulher, atingindo, também, a esfera psicossocial, o bem-estar e a qualidade de vida. OBJETIVO Analisar a ocorrência de disfunções sexuais em mulheres praticantes de voleibol. MATERIAIS E MÉTODOS Foi realizado um estudo descritivo com abordagem quantitativa e caráter transversal. A pesquisa foi realizada com mulheres praticantes de voleibol com idades acima de 35 anos, caracterizando a modalidade máster de voleibol que realizam a atividade. Além disso, deveriam praticar o esporte há pelo menos seis meses com uma frequência de três vezes por semana. A aplicação dos questionários foi realizada durante os treinamentos de uma equipe de voleibol na cidade de Santa Maria --RS. A ocorrência de disfunção sexual foi avaliada através do questionário Female Sexual Function Index (FSFI). RESULTADOS Participaram da pesquisa 11 mulheres praticantes de voleibol com idade média de 40,63. De acordo com o questionário FSFI, 63,63% (n=7) das mulheres apresentaram disfunção no domínio desejo; 18,18% (n=2) no domínio excitação, lubrificação, satisfação e dor e 27,28% (n=3) apresentaram alteração no domínio orgasmo. Apenas 27,28% (n=3) das mulheres praticantes de voleibol apresentaram um valor inferior ao ponto de corte do FSFI, representando alteração na função sexual. MATERIAIS E MÉTODOS De acordo com os dados analisados, a alteração no desejo sexual foi o domínio que apresentou maior índice de disfunção. No entanto, a função sexual no geral, manteve-se preservada na maioria das mulheres. Portanto, conclui-se que a prática de voleibol não possui relação com a ocorrência de disfunções sexuais nessas mulheres. [ABSTRACT FROM AUTHOR]

Copyright of CES Medicina is the property of Universidad CES and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The present study aimed to analyze the influence of episiotomy during intercourse postpartum. This is a review of literature was performed using books, scientific articles published in Portuguese in a time frame from 2003 to 2008, in SciELO databases, Medline and Lilacs. It can be argued that episiotomy has become routine, used prophylactically as justification to avoid perineal trauma morbidity and mortality and gynecological problems such as rectocele, cystocele and relaxation of the pelvic floor. The return to sexual activity varies in a specific time for each woman depending on your libido, "fear", the healing of perineal lacerations or incisions and the degree of vaginal atrophy and secondary episiorrhaphy is an event that affects this time. Many women do not participate in the decision to make or not an episiotomy nor are they informed about the routine practices that bring consequence and influence the quality of sexual life of it. More studies are needed to elucidate the woman feeling underwent episiotomy and the impact on your sex life. [ABSTRACT FROM AUTHOR]

Objective: To update and expand the previous position statement of The North American Menopause Society (NAMS) on the management of symptomatic vulvovaginal atrophy (VVA) in postmenopausal women. Methods: NAMS searched PubMed for medical literature on VVA published since their 2007 position statement on the role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women. A panel of acknowledged experts in the field of genitourinary health reviewed the literature to evaluate new evidence on local estrogen as well as on other management options available or in development for symptomatic VVA. The panel's conclusions and recommendations were reviewed and approved by the NAMS Board of Trustees. Results: Symptomatic VVA can significantly impair the quality of life (QOL) of postmenopausal women and may be underdiagnosed. In most cases, it can be managed successfully. A number of over-the-counter and government-approved prescription therapies available in the United States and Canada demonstrate effectiveness, depending on the severity of VVA symptoms. These include vaginal lubricants and moisturizers, vaginal estrogen, hormone therapy, and the selective estrogen-receptor modulator ospemifene (indicated for dyspareunia). Long-term studies on the endometrial safety of local estrogen and ospemifene are lacking. Changes in the vaginal microbiome have various effects on symptoms. Conclusions: Clinicians can improve the sexual health and QOL of postmenopausal women by educating women about, diagnosing, and appropriately managing symptomatic VVA. Choice of therapy depends on the severity of symptoms, the effectiveness and safety of therapy for the individual patient, and patient preference. Estrogen therapy is the most effective treatment for moderate to severe symptoms, although a direct comparison of estrogen and ospemifene is not available. Nonhormonal therapies available without a prescription provide sufficient relief for most women with mild symptoms. When low-dose estrogen is administered locally, a progestogen is not indicated for women without a uterus and generally is not indicated for women with an intact uterus. However, endometrial safety has not been studied in clinical trials beyond 1 year. There are insufficient data to confirm the safety of local estrogen in women with breast cancer; management of VVA should take the woman's needs and the recommendation of her oncolo gist into consideration. Research on the vaginal microbiome may lead to other therapies in the future. [ABSTRACT FROM AUTHOR]